Leah Kuntz

What are the long term psychiatric and neuropsychiatric complications of COVID-19?

Treating women of reproductive age who have depression can be difficult. Here’s an overview on the subject from the 2022 Annual Psychiatric Times™ World CME Conference.

Can we inherit our parents’ trauma? Research points to yes.

How do you screen for childhood trauma? One doctor at the 2022 Annual Psychiatric Times™ World CME Conference in San Diego, one doctor shared his most helpful tips.

Alzheimer disease psychosis treatment pimavanserin receives Complete Response Letter from the FDA.

This novel schizophrenia treatment showed positive results in a phase 3 trial evaluating efficacy, safety, and tolerability.

A new review shows that there is no convincing evidence that depression is caused low levels of serotonin.

Do you qualify for student loan forgiveness?

Positive results from the phase 3 trial of AD04 show a 79% reduction in heavy drinking.

New results are coming for AD04, a potential treatment for patients with alcohol use disorder.

The new suicide hotline is launching July 16. Are we ready for it?

How can psychedelic research incorporate disability inclusion into future work?

What do psychiatrists think of the overturning of Roe v. Wade?

In this installment of the Around the Practice custom video program, doctors discussed management of narcolepsy.

The American Foundation for Suicide Prevention collaborates with Most Days, a mental health app, to provide suicide prevention expertise and content. Learn more about the partnership here.

Zuranolone, an investigational oral drug being evaluated in women with postpartum depression, sees positive phase 3 study results.

What will society do to children in order to make them win? What should be sacrificed in the name of competition? How much pressure is too much? And how do we pick up the pieces when young athletes are pushed too far?

Axsome Therapeutics announced the robust antidepressant efficacy demonstrated in this latest study.

If you're attending APA 2022 in New Orleans, here are some other things to check out in the city.

Home environments have a clear impact on depression treatment outcomes.

Zuranolone, a drug for the treatment of major depressive disorder and postpartum disorder, is on a rolling submission of a new drug application.

A recent study found a negative association between children with ADHD and health eating patterns.

Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.

If you missed out on the custom Around the Practice video program on naloxone, we've got you covered. Read a recap here.

A recent study examined hyperprolactinemia and antipsychotic therapy in patients with schizophrenia and Hashimoto's thyroiditis.

The FDA has approved dexmedetomidine sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Individuals with depression may be at a greater risk to develop late-onset Alzheimer disease, but a new study suggests depression onset may help predict Alzheimer disease.

What US state has the best mental health care?

Today is World Bipolar Day! Celebrate with the freshest clinical pearls on bipolar disorder that Psychiatric Times has to offer.

Patients with bipolar I disorder and other mental illnesses may be at increased risk for COVID-19 infection.